<DOC>
	<DOCNO>NCT01582061</DOCNO>
	<brief_summary>This study document safety efficacy pasireotide s.c. patient Cushing 's disease .</brief_summary>
	<brief_title>An Open-label , Multi-center , Expanded Access Study Pasireotide s.c. Patients With Cushing 's Disease .</brief_title>
	<detailed_description />
	<mesh_term>Pituitary ACTH Hypersecretion</mesh_term>
	<mesh_term>ACTH-Secreting Pituitary Adenoma</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients confirm diagnosis Cushing 's disease evidence mean urinary free cortisol three 24hour urine sample collect 2week screening period upper limit laboratory normal range morning plasma adrenocorticotropic hormone ( ACTH ) within normal normal range either Magnetic Resonance Imaging ( MRI ) confirmation pituitary adenoma ( great equal 0.6 cm ) , inferior petrosal sinus gradient &gt; 3 corticotrophinreleasing hormone ( CRH ) stimulation patient microadenoma less 0.6 cm , patient prior pituitary surgery , histopathology confirm ACTH stain adenoma . 2 . Patients de novo Cushing 's disease must consider candidate pituitary surgery ( i.e . poor surgical candidate , surgically unapproachable tumor , patient visible pituitary tumor , patient refuse surgical treatment ) 3 . Karnofsky performance status &gt; 60 ( i.e . require occasional assistance , able care personal need ) Exclusion criterion : 1 . Radiotherapy pituitary &lt; 4 week screen patient recover side effect 2 . Patients compression optic chiasm cause acute clinically significant visual field defect 3 . Patients Cushing 's syndrome due ectopic ACTH secretion 4 . Patients hypercortisolism secondary adrenal tumor nodular ( primary ) bilateral adrenal hyperplasia 5 . Patients undergone major surgery within 1 month prior screen 6 . Patients symptomatic cholelithiasis 7 . Patients clinically significant impairment cardiovascular function risk thereof . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Cushing 's disease</keyword>
	<keyword>Hormone disorder</keyword>
	<keyword>Cortisol</keyword>
	<keyword>Adrenocorticotropic hormone</keyword>
	<keyword>Pituitary tumor</keyword>
</DOC>